Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Palatin Technologies News

    1,87 $ -1,06% -0,02 $
    In : 1,7526 € | 17.04.24 21:35:18 NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DTUW
    ISIN: US6960775020
    US-Symbol: PTN
    Typ: Aktie

    Palatin Technologies News

    08.04.24 - PR Newswire
    Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
    Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024 PR ...
    28.02.24 - PR Newswire
    Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
    Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED) PR Newswire
    15.02.24 - PR Newswire
    Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
    Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update PR Newswire
    09.02.24 - PR Newswire
    Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
    Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024 PR Newswire
    05.02.24 - PR Newswire
    Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
    Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED) PR Newswire
    01.02.24 - PR Newswire
    Palatin Announces Closing of $10 Million Registered Direct Offering
    Palatin Announces Closing of $10 Million Registered Direct Offering PR Newswire
    30.01.24 - PR Newswire
    Thinking about buying stock in Arcus Biosciences, Palatin Technologies, Exxon Mobil, Archer Aviation, or Sidus Space ?
    Thinking about buying stock in Arcus Biosciences, Palatin Technologies, Exxon Mobil, Archer Aviation, or Sidus Space ? PR Newswire
    30.01.24 - PR Newswire
    Palatin Announces $10 Million Registered Direct Offering
    Palatin Announces $10 Million Registered Direct Offering PR Newswire
    08.01.24 - PR Newswire
    Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
    Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024 PR Newswire
    22.12.23 - PR Newswire
    Thinking about buying stock in Macy's, Mullen Automotive, Lottery.com, Palatin Technologies, or Reviva Pharmaceuticals?
    Thinking about buying stock in Macy's, Mullen Automotive, Lottery.com, Palatin Technologies, or Reviva Pharmaceuticals? PR Newswire
    20.12.23 - PR Newswire
    Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
    Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million PR Newswire
    18.12.23 - PR Newswire
    Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
    Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American PR Newswire
    14.11.23 - PR Newswire
    Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
    Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update PR Newswire
    09.11.23 - PR Newswire
    Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023
    Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023 PR Newswire
    24.10.23 - PR Newswire
    Palatin Announces Closing of $5 Million Registered Direct Offering
    Palatin Announces Closing of $5 Million Registered Direct Offering PR Newswire
    23.10.23 - PR Newswire
    Palatin Announces $5 Million Registered Direct Offering
    Palatin Announces $5 Million Registered Direct Offering PR Newswire
    19.10.23 - PR Newswire
    Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results
    Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results PR Newswire
    18.10.23 - PR Newswire
    Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese Patients
    Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese Patients PR Newswire
    16.10.23 - PR Newswire
    Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis Treatment
    Palatin Presents Data at the United European Gastroenterology Week 2023 Conference On PL8177 Ulcerative Colitis Treatment PR Newswire
    13.10.23 - PR Newswire
    Palatin Receives Notice of Non-Compliance from NYSE American
    Palatin Receives Notice of Non-​Compliance from NYSE American PR Newswire

    Newssuche

    Videos

    newspaper
    16.04.24 -9,52%
    Technical Trading: Natural Gas Long Chance
    Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »